Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin, Fludarabine, Cytarabine and Rituximab in Richter's Transformation, PLL or Refractory/Relapsed B-Cell CLL
NCT00452374Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2004
- Primary completion
- Jan 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in Richter's syndrome (RS), prolymphocytic leukemia (PLL), chronic lymphocytic leukemia (CLL), sponsored by University of Texas MD Anderson Cancer Center. Started Nov 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
Richter's syndrome (RS)prolymphocytic leukemia (PLL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00452374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00452374.